Showing results (421-430 of 661) with videos related to
Sort By:
Pageof 67
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2014
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unitKhurum Khan, Joo Ern Ang, Naureen Starling, et al.Blood|May 1, 2004
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responsesDonald W Milligan, Savio Fernandes, Ranjit Dasgupta, et al.Archives of Disease in Childhood|December 18, 2016
Ethnic and socioeconomic variation in incidence of congenital heart defectsRachel L Knowles, Deborah Ridout, Sonya Crowe, et al.Current Oncology (Toronto, Ont.)|June 25, 2025
Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency AblationJennifer W S Pang, Daniel Tong, Nicos Fotiadis, et al.Clinical Colorectal Cancer|March 18, 2004
Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinomaTimothy J Price, Paul J Ross, Tamas Hickish, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 16, 2015
Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantationStuart W Grant, Graeme L Hickey, Peter Ludman, et al.Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 21, 2018
Exercise intensity affects acute neurotrophic and neurophysiological responses poststrokePierce Boyne, Colleen Meyrose, Jennifer Westover, et al.Journal for Immunotherapy of Cancer|December 17, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1Gary Middleton, Charlotte Gaskell, Joshua Savage, et al.International Journal of Cancer|December 31, 2013
Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancerMaressa A Bruhn, Amanda R Townsend, Chee Khoon Lee, et al.Pageof 67